WCLC 2026: What's New in Lung Cancer Treatment? | 13th OncoWisdom Webinar

What’s new in lung cancer treatment following WCLC 2026? Watch the 13th OncoWisdom Webinar featuring key research updates and expert discussions from the World Conference on Lung Cancer (WCLC) 2026. Moderated by Dr. Amol Akhade, Medical Oncologist, Mumbai, this educational webinar brings together international oncology experts to examine recent clinical trial results, emerging treatment strategies, and their implications for everyday oncology practice. *Key Topics Discussed:* Major clinical trial updates from WCLC 2026 Small Cell Lung Cancer (SCLC): Emerging antibody-drug conjugates and treatment sequencing The MAVERICK trial: Prophylactic Cranial Irradiation (PCI) versus MRI surveillance Tarlatamab and emerging DLL3-targeted therapies HER2-directed treatments and trastuzumab deruxtecan EGFR-mutated non-small cell lung cancer (NSCLC) EGFR exon 20 insertion mutations and targeted therapies ROS1-positive lung cancer treatment developments ADAURA long-term survival updates Neoadjuvant and perioperative treatment approaches The HARMONi trials and PD-1/VEGF bispecific antibodies Antibody-drug conjugates and immunotherapy in PD-L1-high NSCLC Treatment sequencing, biomarkers, toxicity and clinical decision-making *Moderator:* Dr. Amol Akhade Medical Oncologist, Mumbai, India *Webinar Series:* 13th OncoWisdom Webinar *About OncoWisdom* OncoWisdom is an educational platform connecting oncology professionals through scientific webinars, clinical research updates and expert discussions focused on evidence-based cancer care. Subscribe for more oncology webinars, international conference updates and expert perspectives on advances in cancer treatment. *Medical Disclaimer:* This webinar is intended for medical education and professional discussion. Clinical trial findings and expert opinions should be interpreted alongside current clinical guidelines, regulatory approvals and individual patient circumstances. This content does not constitute personalized medical advice. 00:00 Introduction – 13th OncoWisdom Webinar 01:19 WCLC 2026 – Major Clinical Trial Updates 01:52 B7-H3 Antibody-Drug Conjugates in SCLC 04:55 MAVERICK Trial – MRI Surveillance vs PCI 06:36 Tarlatamab – Dosing and New Formulations 08:39 HER2-Directed Therapy Updates 10:43 EGFR Exon 20 and ROS1 Treatment Advances 11:25 ADAURA and Early-Stage Lung Cancer Updates 15:19 Expert Panel Discussion Begins 16:38 MAVERICK Trial – Expert Perspectives 28:07 HARMONi-2 and PD-L1-High NSCLC 32:47 Immunotherapy and ADC Trial Discussion 42:32 Treatment After EGFR TKI Progression 45:02 ADAURA and Adjuvant Treatment Discussion 59:56 Comparing EGFR Exon 20 Treatment Options 1:01:54 Future Lung Cancer Research 1:02:48 Closing Remarks #WCLC2026 #LungCancer #OncoWisdom #MedicalOncology #NSCLC #SCLC